Novartis pays $25 million to SEC to resolve China FCPA offenses
Pharma giant Novartis AG agreed Wednesday to pay $25 million to settle charges that it violated the Foreign Corrupt Practices Act when two China-based subsidiaries bribed doctors and others to prescribe its drugs. … Continue Reading